These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17570008

  • 1. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
    Santiago M, Baron M, Miyachi K, Fritzler MJ, Abu-Hakima M, Leclercq S, Bell M, Hudson M, Mathieu JP, Taillefer S, Jones N, Docherty P, Khraishi M, Markland J, Pope J, Robinson D, Smith D, Sutton E.
    Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD, Hill HR, Russo KL, Lakos G, Szekanecz Z, Teodorescu M.
    J Rheumatol; 2010 Aug 01; 37(8):1582-8. PubMed ID: 20516016
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
    Morita Y, Muro Y, Sugiura K, Tomita Y.
    Clin Exp Rheumatol; 2008 Aug 01; 26(4):542-7. PubMed ID: 18799082
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
    Debaugnies F, Servais G, Badot V, Noubouossie D, Willems D, Corazza F.
    Scand J Rheumatol; 2013 Aug 01; 42(2):108-14. PubMed ID: 23126558
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
    Bertin D, Dubucquoi S, Lakomy D, Deleplancque AS, Desplat-Jégo S.
    Immunol Res; 2016 Apr 01; 64(2):455-60. PubMed ID: 26350265
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population.
    Szekanecz Z, Szabó Z, Zeher M, Soós L, Dankó K, Horváth I, Lakos G.
    Immunol Res; 2013 Jul 01; 56(2-3):439-43. PubMed ID: 23592053
    [Abstract] [Full Text] [Related]

  • 17. Comparison of second- and third-generation immunoassays for detection of anti-cyclic citrullinated peptide antibodies.
    Ji M, Hur M, Moon HW, Park M, Yun YM, Lee SH.
    Scand J Clin Lab Invest; 2018 Oct 01; 78(6):477-482. PubMed ID: 30073867
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis.
    Luis Caro-Oleas J, Fernández-Suárez A, Reneses Cesteros S, Porrino C, Núñez-Roldán A, Wichmann Schlipf I.
    Clin Chem Lab Med; 2007 Oct 01; 45(10):1396-401. PubMed ID: 17924851
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.